×
About 1,320 results

ALLMedicine™ Cerebral Venous Thrombosis Center

Research & Reviews  460 results

Comparison of susceptibility-weighted angiography (SWAN) and T2 gradient-echo sequences...
https://doi.org/10.1177/19714009221109885
The Neuroradiology Journal; Boukobza M, Guinebert S et. al.

Jun 21st, 2022 - To assess the diagnostic accuracy and lesion conspicuity of susceptibility-weighted angiography (SWAN) and T2* for the clot detection in acute cerebral venous thrombosis (CVT) by comparison with contrast-enhanced MR venography. Venous thrombi dete...

Bilateral parafalcine cortical and leptomeningeal impairment in MOG antibody disease an...
https://doi.org/10.1016/j.jneuroim.2022.577898
Journal of Neuroimmunology; Jiang W, Sun X et. al.

Jun 20th, 2022 - Bilateral parafalcine cortical and leptomeningeal impairment (BPCLI) is a rare finding observed in cases of myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOGAD) and neuromyelitis optica spectrum disorders (NMOSD). The failure to reco...

Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and...
https://doi.org/10.1001/jamanetworkopen.2022.17375
JAMA Network Open; Dag Berild J, Bergstad Larsen V et. al.

Jun 15th, 2022 - Vaccinations are paramount to halt the COVID-19 pandemic, and safety data are essential to determine the risk-benefit ratio of each COVID-19 vaccine. To evaluate the association between the AZD1222, BNT162b2, and mRNA-1273 vaccines and subsequent ...

Management of cerebral venous thrombosis due to adenoviral COVID-19 vaccination.
https://doi.org/10.1002/ana.26431
Annals of Neurology; Scutelnic A, Krzywicka K et. al.

Jun 12th, 2022 - Cerebral venous thrombosis caused by vaccine-induced immune thrombotic thrombocytopenia (VITT-CVT) is a rare adverse effect of adenovirus-based SARS-CoV-2 vaccines. In March 2021, after autoimmune pathogenesis of VITT was discovered, treatment rec...

Endovascular and Medical Management of Cerebral Venous Thrombosis: A Systematic Review ...
https://doi.org/10.1016/j.wneu.2022.05.142
World Neurosurgery; Naik A, Smith E et. al.

Jun 11th, 2022 - Management of cerebral venous thrombosis (CVT) involves minimizing expansion of the thrombus and promoting the recanalization of the venous sinus. While current guidelines include indications of endovascular management, and anticoagulation with he...

see more →

Guidelines  2 results

European Stroke Organization guideline for the diagnosis and treatment of cerebral veno...
https://doi.org/10.1111/ene.13381
European Journal of Neurology; Ferro JM, Bousser MG et. al.

Aug 24th, 2017 - Current guidelines on cerebral venous thrombosis (CVT) diagnosis and management were issued by the European Federation of Neurological Societies in 2010. We aimed to update the previous European Federation of Neurological Societies guidelines usin...

New guidelines for the management of cerebral venous thrombosis.
https://doi.org/10.1227/01.neu.0000400016.31648.3f
Neurosurgery Aoun SG, Rahme RJ et. al.

Jul 28th, 2011 - New guidelines for the management of cerebral venous thrombosis.|2011|Aoun SG,Rahme RJ,Batjer HH,Bendok BR,|therapeutic use,diagnosis,therapy,diagnosis,therapy,

see more →

Drugs  1 results see all →

Clinicaltrials.gov  21 results

The Norwegian Cerebral Venous Thrombosis Study
https://clinicaltrials.gov/ct2/show/NCT05021198

Jun 8th, 2022 - A retrospective hospital-based chart review will be conducted at eight different hospitals covering all four health regions and more than 3 million inhabitants in Norway. These eight hospitals are Akershus University Hospital, Haukeland University...

Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
https://clinicaltrials.gov/ct2/show/NCT03329365

May 11th, 2022 - Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired clonal hematological disorder leading to red blood cells hemolysis and thrombosis. PNH has been reported to be the cause of cerebral venous thrombosis and embolic ischemic strokes and is...

Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
https://clinicaltrials.gov/ct2/show/NCT04660747

Feb 28th, 2022 - Rationale: Patients with cerebral venous thrombosis (CVT) are currently treated with anticoagulants during 3-12 months after diagnosis, to prevent worsening of the CVT and recurrent thrombosis, and to promote venous recanalization. Until recently,...

Cytokine Registry Database of Stroke Patients
https://clinicaltrials.gov/ct2/show/NCT03297827

Feb 8th, 2022 - Stroke is the fifth cause of all-cause mortality in US http://www.cdc.gov/stroke/facts.htm . Early identification and treatment not only prevent mortality but also morbidity. Recent advancement in the imaging and diagnostic technique and novel the...

Global Impact of the COVID 19 Pandemic on Stroke Care, Cerebral Venous Thrombosis, and Subarachnoid Hemorrhage
https://clinicaltrials.gov/ct2/show/NCT04934020

Dec 14th, 2021 - This is a retrospective, observational, cross-sectional, international study, across 6 continents, and estimated 100 stroke centers. The stroke metric diagnoses will be identified by their International Classification of Diseases version 10 (ICD-1...

see more →

News  44 results

Neurologic Complications Rare After COVID-19 Vaccines
https://www.medpagetoday.com/neurology/generalneurology/97590

Mar 9th, 2022 - Neurologic adverse events after COVID-19 vaccination were rare, an analysis of Vaccine Adverse Event Reporting System (VAERS) data showed. Of nearly 307 million COVID vaccine doses administered in the U.S. in the first half of 2021, 314,610 (0.1%)...

Headache and Covid-19: What clinicians should know
https://www.mdedge.com/migraine-icymi/article/252097/headache-migraine/headache-and-covid-19-what-clinicians-should-know
Edoardo Caronna, MD and Patricia Pozo-Rosich et. al.

Feb 23rd, 2022 - Edoardo Caronna, MD and Patricia Pozo-Rosich, MD, PhD, Neurology Department, Hospital Universitari Vall d’Hebron, Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; and Headache and Neurological Pain Research Group, Vall.

DOACs Comparable to Warfarin in CVT
https://www.medscape.com/viewarticle/968526

Feb 15th, 2022 - Use of direct oral anticoagulant drugs (DOACs) appears to be just as effective as warfarin in preventing future thrombotic events in patients with cerebral venous thrombosis (CVT) stroke, and are less likely to result in major bleeding, a retrospe...

Reaching Conclusions From Limited Data Holds Pitfalls
https://www.onclive.com/view/reaching-conclusions-from-limited-data-holds-pitfalls

Oct 6th, 2021 - There are most interesting and complex days in the continuing evolution of the COVID-19 pandemic. On one hand, in the United States and a number of other countries, mass vaccination strategies have finally begun to have a major impact on the incid...

Expert Recommendations on the Diagnosis and Management of Long COVID
https://www.medscape.com/viewarticle/960243

Oct 5th, 2021 - It is estimated that one million people in the UK are currently living with long COVID, and with the total number of UK COVID-19 cases nearing 8 million, the further implications of long COVID for patients and healthcare services is uncertain. As ...

see more →